Drug Information

Drug General Information
Drug ID
D0W5NP
Former ID
DIB014324
Drug Name
Anatumomab mafenatox
Synonyms
ABR-214936; Fab5T4V13-SEAm9; PNU-214936; TTS-CD2; CD-2, Active Biotech
Drug Type
Antibody
Indication Breast cancer [ICD9: 174, 175; ICD10:C50] Terminated [528658]
Company
Pharmacia & Upjohn Inc
Target and Pathway
Target(s) 5T4 ONCOFETAL antigen Target Info [528658]
References
Ref 528658A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma. Br J Cancer. 2007 Feb 26;96(4):567-74. Epub 2007 Feb 6.
Ref 528658A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma. Br J Cancer. 2007 Feb 26;96(4):567-74. Epub 2007 Feb 6.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.